4.7 Review

Current perspectives on FOXA1 regulation of androgen receptor signaling and prostate cancer

期刊

GENES & DISEASES
卷 2, 期 2, 页码 144-151

出版社

ELSEVIER
DOI: 10.1016/j.gendis.2015.01.003

关键词

Androgen receptor; Chromatin accessibility; EMT; FOXA1; Pioneering factor; Prostate cancer

资金

  1. NIH [R01CA172384]
  2. U.S. Department of Defense [W81XWH-13-1-0319, W81XWH-14-1-0023]
  3. American Cancer Society [RSG-12-085-01]
  4. NIH/NCI [T32 CA09560]

向作者/读者索取更多资源

FOXA1 (also known as hepatocyte nuclear factor 3 alpha, or HNF-3 alpha) is a protein of the FKHD family transcription factors. FOXA1 has been termed as a pioneer transcription factor due to its unique ability of chromatin remodeling in which the chromatin can be decompacted to allow genomic access by nuclear hormone receptors, including androgen receptor (AR) and estrogen receptor (ER). In this review, we discuss our current understanding of FOXA1 regulation of prostatic and non-prostatic AR-chromatin targeting. We present an updated model wherein FOXA1: AR equilibrium in the nuclei defines prostatic AR binding profile, which is perturbed in prostate cancer with FOXA1 and/or AR de-regulation. Finally, we discuss recent efforts in exploring new horizons of AR-independent functions of FOXA1 in prostate cancer and interesting directions to pursue in future studies. Copyright (C) 2015, Chongqing Medical University. Production and hosting by Elsevier B.V. This is an open access article under the CC BY-NC-ND license

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据